The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 25, 2019

Filed:

Jun. 12, 2015
Applicant:

Tenboron Oy, Helsinki, FI;

Inventors:

Anne Leppanen, Vantaa, FI;

Filip S. Ekholm, Porvoo, FI;

Jari Helin, Rajamaki, FI;

Hanna Salo, Helsinki, FI;

Anne Kanerva, Helsinki, FI;

Assignee:

TENBORON OY, Helsinki, FI;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 41/00 (2006.01); A61K 47/68 (2017.01); A61K 31/721 (2006.01); C07K 16/28 (2006.01); C07K 16/30 (2006.01); C07K 14/245 (2006.01);
U.S. Cl.
CPC ...
A61K 41/0095 (2013.01); A61K 31/721 (2013.01); A61K 47/6849 (2017.08); A61K 47/6883 (2017.08); C07K 14/245 (2013.01); C07K 16/2863 (2013.01); C07K 16/30 (2013.01); A61K 2039/505 (2013.01); C07K 2317/14 (2013.01); C07K 2317/24 (2013.01); C07K 2317/51 (2013.01); C07K 2317/515 (2013.01); C07K 2317/55 (2013.01); C07K 2317/56 (2013.01); C07K 2317/622 (2013.01); C07K 2317/77 (2013.01); C07K 2317/94 (2013.01);
Abstract

The present invention relates to a conjugate comprising an anti-EGFR1 antibody or an EGFR binding fragment thereof and at least one dextran derivative, wherein the dextran derivative comprises at least one D-glucopyranosyl unit, wherein at least one carbon selected from carbon 2, 3 or 4 of the at least one D-glucopyranosyl unit is substituted by a substituent of the formula —O—(CH)—S—BHwherein n is in the range of 3 to 10; and the dextran derivative is bound to the anti-EGFR antibody or an EGFR1 binding fragment thereof via a bond formed by a reaction between at least one aldehyde group formed by oxidative cleavage of a D-glucopyranosyl unit of the dextran derivative and an amino group of the anti-EGFR1 antibody or an EGFR1 binding fragment thereof.


Find Patent Forward Citations

Loading…